Home › Compare › WACMF vs ABBV
WACMF yields 4.07% · ABBV yields 3.06%● Live data
📍 WACMF pulled ahead of the other in Year 2
Combined, WACMF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of WACMF + ABBV for your $10,000?
Wacom Co., Ltd. develops, manufactures, and sells electronic devices and related software worldwide. It provides input components and sensor systems to manufacturers of smartphones, tablets, and notebook PCs. The company also offers pen computers, such as MobileStudio Pro; pen displays, including Wacom One, Cintiq 13HD, Cintiq 22HD, Cintiq 22HD touch, Cintiq 27QHD, Cintiq 27QHD touch, Wacom Cintiq, and Wacom Cintiq Pro; pen tablets comprising Wacom Intuos, Wacom Intuos Pro, and Wacom Intuos Pro Paper; and smart pads consisting of Bamboo Slate and Bamboo Folio. In addition, it provides Bamboo Ink, Bamboo Ink Plus, Bamboo Sketch, Bamboo Solo, Bamboo Duo, Bamboo Fineline, and Bamboo Alpha styluses; and apps and services, such as Bamboo Paper, Inkspace, and Wacom Notes. Wacom Co., Ltd. was incorporated in 1983 and is headquartered in Kazo, Japan.
Full WACMF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.